MNKD FY 2019 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$841M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$63M+126.3% YoY

Gross Profit

$35M55.6% margin

Operating Income

-$45M-70.7% margin

Net Income

-$52M-82.3% margin

EPS (Diluted)

$-0.31

Cash Flow

Operating Cash Flow

-$88M

Free Cash Flow

-$91M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$94M

Total Liabilities

$284M

Stockholders' Equity

-$191M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$63M	$28M	+126.3%
Gross Profit	$35M	$7M	+375.1%
Operating Income	-$45M	-$77M	+41.8%
Net Income	-$52M	-$87M	+40.3%